Sign in
Taking peopleNo phase

Myopia Control Combined PBM With Myopic Defocus Lens in Children

Key facts

Who runs it
Beijing Airdoc Technology Co., Ltd.
Where
China1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
304 people, planned
Started
12 Dec 2022
Expected to end
31 Dec 2027
Type of study
Interventional, 4 groupsOne group gets a placebo (a dummy treatment), for comparison.
Treatments tested
  • PBM
  • Peripheral defocus spectacles
  • Single vision spectacles
Record updated
9 March 2023

Who can take part

Age
6 years to 13 years
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (12)Hide the full registry criteria

Who can take part

  • Informed consent by the supervision of the children
  • 6~13 years old (including both the 6 and 13)
  • SE range: -0.50~-5.50D
  • Astigmatism <=2.00D
  • BCVA >=0.8
  • Anisometropia <=1.50D
  • Confirmed to no use of other myopia control intervention

Who cannot take part

  • Ocular lesions to effect vision or diseases (such as cataract, glaucoma, marcular pathology, cornea lesions, uveitis, retina detachment, congential opitc abnormal and etc.)
  • Systom disease: immune disease, central nerve system, Down syndrome, asthma, severe cardiopulmonary abnormal, severe liver and renal dysfunction
  • Halo, glare, toutic, ADHD, psoriasis
  • Squint, ocular lesion or acute imflammation
  • Other myopia control interventions within recent 3 month such as atropine, device, orthokeratology, multi-focus soft lens, multi-function spectacles

Eligibility questionnaire

From the criteria published for this trial, to help you prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Age

This trial is currently available in China.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

To study the efficacy of myopi control with two methods: low lever red light and peripheral defocus spectacles with four groups and design with prospective, double-blind, randimized, and with control for 6 month.

The 4 groups in the trial

  • PBM therapy + SVSTreatment being tested

    Low lever red light therapy with single vision spectacles

    Treatment: PBM and Single vision spectacles

  • Peripheral defocus spectaclesTreatment being tested

    a spectacles with special design with peripheral myopic defocus to control myopia progression

  • PBM +Peripheral defocus spectaclesTreatment being tested

    Low lever red light therapy with a spectacles with special design with peripheral myopic defocus to control myopia progression

    Treatment: PBM and Peripheral defocus spectacles

  • ControlPlacebo, for comparison

    single vision spectacles only as the control

    Treatment: Single vision spectacles

Next steps

For your doctor

Doctor ask sheet

A PDF for your doctor: what this trial tests, who can take part, and 1 eligibility question with room for answers and notes.

Download the PDF

PDF, US Letter, 1 to 2 pages. A4 size

For the study team

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Myopia Control Combined PBM With Myopic Defocus Lens in Children: Double-blind RCT for 6 Month
Criteria questions
Built from NCT05756959, who can take part
Record updated
9 March 2023